fromilid 500 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - klaritromicin - filmom obložena tableta - 500 mg/1 tableta - 1 filmom obložena tableta sadrži: 500 mg klaritromicina
fromilid 250 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - klaritromicin - filmom obložena tableta - 250 mg/1 tableta - 1 filmom obložena tableta sadrži: 250 mg klaritromicina
sorafenib sandoz 200 mg/1 tableta filmom obložena tableta
sandoz d.o.o. - sorafenib - filmom obložena tableta - 200 mg/1 tableta - jedna filmom obložena tableta sadrži 200 mg sorafeniba (u obliku tosilata)
sorafenib sandoz 200 mg/1 tableta filmom obložena tableta
sandoz d.o.o. - sorafenib - filmom obložena tableta - 200 mg/1 tableta - jedna filmom obložena tableta sadrži 200 mg sorafeniba (u obliku tosilata)
sorafenib mylan 200 mg/1 tableta film tableta
viatris bh d.o.o. - sorafenib - film tableta - 200 mg/1 tableta - 1 film tableta sadrži 200 mg sorafeniba (u obliku sorafenib tosilata)
sorafenib stada 200 mg/1 tableta film tableta
hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - sorafenib - film tableta - 200 mg/1 tableta - 1 film tableta sadrži: 200 mg sorafeniba u obliku sorafenib tosilata
sorafenib stada 400 mg/1 tableta film tableta
hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - sorafenib - film tableta - 400 mg/1 tableta - 1 film tableta sadrži: 400 mg sorafeniba u obliku sorafenib tosilata
lunsumio
roche registration gmbh - mosunetuzumab - limfom, folikularni - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
carvykti
janssen-cilag international nv - ciltacabtagene autoleucel - multipli mijelom - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
kimmtrak
immunocore ireland limited - tebentafusp - uveal neoplasms - antineoplastična sredstva - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.